Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Malignant glioma: lessons from genomics, mouse models, and stem cells.

Chen J, McKay RM, Parada LF.

Cell. 2012 Mar 30;149(1):36-47. doi: 10.1016/j.cell.2012.03.009. Review.


The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.

Lee DW, Ramakrishnan D, Valenta J, Parney IF, Bayless KJ, Sitcheran R.

PLoS One. 2013;8(2):e57489. doi: 10.1371/journal.pone.0057489. Epub 2013 Feb 25.


Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion.

Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA.

J Natl Cancer Inst. 2011 Aug 3;103(15):1162-78. doi: 10.1093/jnci/djr224. Epub 2011 Jul 19.


The role of glioma stem cells in glioma tumorigenesis.

Yin CL, Lv SQ, Chen XY, Guo H.

Front Biosci (Landmark Ed). 2014 Jan 1;19:818-24. Review.


Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.

Stoltz K, Sinyuk M, Hale JS, Wu Q, Otvos B, Walker K, Vasanji A, Rich JN, Hjelmeland AB, Lathia JD.

Neuro Oncol. 2015 Mar;17(3):361-71. doi: 10.1093/neuonc/nou320. Epub 2014 Nov 21.


Cancer stem cells and the biology of brain tumors.

Flores DG, Ledur PF, Abujamra AL, Brunetto AL, Schwartsmann G, Lenz G, Roesler R.

Curr Stem Cell Res Ther. 2009 Dec;4(4):306-13. Review.


Molecular pathogenesis of malignant glial tumors.

Jones TS, Holland EC.

Toxicol Pathol. 2011 Jan;39(1):158-66. doi: 10.1177/0192623310387617. Epub 2010 Nov 15.


Gliomagenesis: genetic alterations and mouse models.

Holland EC.

Nat Rev Genet. 2001 Feb;2(2):120-9. Review.


Brain tumor stem cells as therapeutic targets in models of glioma.

Laks DR, Visnyei K, Kornblum HI.

Yonsei Med J. 2010 Sep;51(5):633-40. doi: 10.3349/ymj.2010.51.5.633. Review.


Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.

Huang Q, Zhang QB, Dong J, Wu YY, Shen YT, Zhao YD, Zhu YD, Diao Y, Wang AD, Lan Q.

BMC Cancer. 2008 Oct 22;8:304. doi: 10.1186/1471-2407-8-304.


TGF-β induces miR-182 to sustain NF-κB activation in glioma subsets.

Song L, Liu L, Wu Z, Li Y, Ying Z, Lin C, Wu J, Hu B, Cheng SY, Li M, Li J.

J Clin Invest. 2012 Oct;122(10):3563-78. doi: 10.1172/JCI62339. Epub 2012 Sep 24.


MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.

Jiang L, Lin C, Song L, Wu J, Chen B, Ying Z, Fang L, Yan X, He M, Li J, Li M.

J Clin Invest. 2012 Jan;122(1):33-47. doi: 10.1172/JCI58849. Epub 2011 Dec 12.


Tie2/TEK modulates the interaction of glioma and brain tumor stem cells with endothelial cells and promotes an invasive phenotype.

Liu D, Martin V, Fueyo J, Lee OH, Xu J, Cortes-Santiago N, Alonso MM, Aldape K, Colman H, Gomez-Manzano C.

Oncotarget. 2010 Dec;1(8):700-9.


Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.

Watanabe A, Mabuchi T, Satoh E, Furuya K, Zhang L, Maeda S, Naganuma H.

J Neurooncol. 2006 Mar;77(1):25-32.


Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.

Li J, Gong LY, Song LB, Jiang LL, Liu LP, Wu J, Yuan J, Cai JC, He M, Wang L, Zeng M, Cheng SY, Li M.

Am J Pathol. 2010 Feb;176(2):699-709. doi: 10.2353/ajpath.2010.090502. Epub 2009 Dec 24.


MEF promotes stemness in the pathogenesis of gliomas.

Bazzoli E, Pulvirenti T, Oberstadt MC, Perna F, Wee B, Schultz N, Huse JT, Fomchenko EI, Voza F, Tabar V, Brennan CW, DeAngelis LM, Nimer SD, Holland EC, Squatrito M.

Cell Stem Cell. 2012 Dec 7;11(6):836-44. doi: 10.1016/j.stem.2012.09.012.


New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.

Zhao B, Bian EB, Li J, Li J.

J Cell Physiol. 2014 Sep;229(9):1141-7. doi: 10.1002/jcp.24540. Review.


Glioma models.

Dai C, Holland EC.

Biochim Biophys Acta. 2001 Aug 31;1551(1):M19-27. Review.


[Biology of gliomas].

Ducray F.

Cancer Radiother. 2008 Nov;12(6-7):663-8. doi: 10.1016/j.canrad.2008.09.001. Epub 2008 Oct 1. Review. French.


Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.

Bourkoula E, Mangoni D, Ius T, Pucer A, Isola M, Musiello D, Marzinotto S, Toffoletto B, Sorrentino M, Palma A, Caponnetto F, Gregoraci G, Vindigni M, Pizzolitto S, Falconieri G, De Maglio G, Pecile V, Ruaro ME, Gri G, Parisse P, Casalis L, Scoles G, Skrap M, Beltrami CA, Beltrami AP, Cesselli D.

Stem Cells. 2014 May;32(5):1239-53. doi: 10.1002/stem.1605.

Supplemental Content

Support Center